activins and Pituitary Neoplasms

activins has been researched along with Pituitary Neoplasms in 28 studies

Research

Studies (28)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (3.57)	18.7374
1990's	12 (42.86)	18.2507
2000's	11 (39.29)	29.6817
2010's	1 (3.57)	24.3611
2020's	3 (10.71)	2.80

Authors

Authors	Studies
Abeledo-Machado, A; Camilletti, MA; Diaz-Torga, G; Faraoni, EY; Gutierrez, S; Marcial López, CA; Peña-Zanoni, M; Perez, PA; Rulli, SB	1
Bertolino, P; Chanal, M; De Alcubierre, D; Ilie, MD; Pasternack, A; Raverot, G; Raymond, P; Ritvos, O; Ziverec, A	1
Abeledo Machado, AI; Camilletti, MA; Díaz-Torga, G; Faraoni, EY; Gutiérrez, S; Marcial López, CA; Peña-Zanoni, M; Pérez, PA; Rulli, SB	1
Auger, C; Bertolino, P; Chanal, M; Gadet, R; Hennino, A; Jouanneau, E; Karam, V; Mikaélian, I; Principe, M; Raverot, G; Raverot, V; Vasiljevic, A; Wierinckx, A	1
Lebrun, JJ	1
Danila, DC; Haidar, JN; Klibanski, A; Zhang, X; Zhou, Y	1
Kishida, M; Makino, H; Ogura, T; Otsuka, F; Suzuki, J; Takeda, M; Tamiya, T	1
Inagaki, K; Makino, H; Mimura, Y; Miyoshi, T; Ogura, T; Otani, H; Otsuka, F; Suzuki, J; Takeda, M	1
Gaddy-Kurten, D; Vale, WW	1
Franzén, P; Heldin, CH; Miyazono, K; Okadome, T; ten Dijke, P; Yamashita, H	1
Asa, SL; Bashey, HM; Cirullo, R; Gennarelli, TA; Haddad, G; Penabad, JL; Snyder, PJ	1
Daniels, M; Dewar, JH; Harris, PE; James, RA; Kendall-Taylor, P; Turner, SJ	1
Alexander, JM; Bikkal, HA; Klibanski, A; Laws, ER; Zervas, NT	1
Huang, G; Li, SQ; Ying, C; Ying, SY; Zhang, Z	1
Aiba, M; Demura, H; Demura, R; Eto, Y; Kubo, O; Suzuki, T; Tajima, S; Takakura, K; Yajima, R	1
Matsuno, A; Osamura, RY; Sanno, N; Sugiyama, M; Tahara, S; Takumi, I; Teramoto, A	1
Alexander, JM; Danila, DC; Hedley-Whyte, ET; Inder, WJ; Klibanski, A; Swearingen, B; Zhang, X	1
Danila, DC; Dickersin, GR; Fletcher, JA; Hedley-Whyte, ET; Johnson, SR; Klibanski, A; Selig, MK; Zhang, X; Zhou, Y	1
Aono, T; Irahara, M; Kuwahara, A; Sugino, H; Tamura, N; Ushigoe, K	1
Danila, DC; Johnson, SR; Klibanski, A; Sigai, DP; Sun, H; Zhang, X; Zhou, Y	1
de Herder, WW; de Jong, FH; Hofland, LJ; van der Wal, R; van Gastel, L; van Koetsveld, PM; Wessels, HT	1
Capella, C; Genasetti, A; La Rosa, S; Uccella, S	1
Holmes, WE; Keutmann, HT; Pan, Y; Schneyer, AL; Sidis, Y; Tortoriello, DV	1
Kitaoka, M; Kojima, I; Ogata, E; Takano, K; Teramoto, A; Yamashita, N	1
Alexander, JM; Bikkal, HA; Jameson, JL; Klibanski, A; Schwall, RH	1
Kitaoka, M; Kojima, I; Ogata, E; Takano, K; Tanaka, Y; Teramoto, A	1
Ramsdell, JS	1
Cheifetz, S; Guillemin, R; Ling, N; Massagué, J	1

Reviews

1 review(s) available for activins and Pituitary Neoplasms

Article	Year
Activin, TGF-beta and menin in pituitary tumorigenesis. Advances in experimental medicine and biology, 2009, Volume: 668 Topics: Activins; Adenoma; Gene Expression Regulation, Neoplastic; Humans; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2009

Other Studies

27 other study(ies) available for activins and Pituitary Neoplasms

Article	Year
Oophorectomy improves pituitary activin inhibitory function preventing lactotroph hyperplasia development. Endocrine-related cancer, 2022, 05-11, Volume: 29, Issue:6 Topics: Activins; Adult; Animals; Female; Humans; Hyperplasia; Inhibins; Lactotrophs; Mice; Ovariectomy; Pituitary Neoplasms; Prolactin; Prolactinoma	2022
Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouse. Endocrine-related cancer, 2023, 03-01, Volume: 30, Issue:3 Topics: Activins; Animals; Endothelial Cells; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Gonadotrophs; Humans; Mice; Pituitary Gland; Pituitary Neoplasms; Tumor Microenvironment	2023
Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia. The Journal of endocrinology, 2020, 02-01, Volume: 244, Issue:2 Topics: Activins; Animals; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Genotype; Lactotrophs; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; RNA, Messenger; Sex Factors; Transcription Factor Pit-1	2020
ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation. Endocrine-related cancer, 2018, Volume: 25, Issue:9 Topics: Activin Receptors, Type I; Activins; Animals; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats	2018
Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:10 Topics: Activin Receptors, Type I; Activins; Alternative Splicing; Animals; Cell Division; Cell Line; DNA; Enzyme-Linked Immunosorbent Assay; Gene Expression; Humans; Luciferases; Mink; Phosphorylation; Pituitary Neoplasms; Protein Isoforms; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transfection; Tumor Cells, Cultured	2002
Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. Biochemical and biophysical research communications, 2003, Jul-11, Volume: 306, Issue:4 Topics: Activins; Adenoma; Adult; Aged; Bone Morphogenetic Proteins; Cell Division; Female; Follicle Stimulating Hormone; Follistatin; Gonadotropin-Releasing Hormone; Humans; Ligands; Luteinizing Hormone; Male; Middle Aged; Models, Biological; Pituitary Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Time Factors	2003
Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells. The Journal of endocrinology, 2007, Volume: 194, Issue:1 Topics: Activins; Animals; Bone Morphogenetic Proteins; Cell Line, Tumor; Follistatin; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gonadotropins; Ligands; Mice; Microscopy, Fluorescence; Mitosis; Oligonucleotide Array Sequence Analysis; Peroxisome Proliferator-Activated Receptors; Pituitary Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic	2007
Activin increases phosphorylation and decreases stability of the transcription factor Pit-1 in MtTW15 somatotrope cells. The Journal of biological chemistry, 1995, Dec-01, Volume: 270, Issue:48 Topics: Activins; DNA; DNA-Binding Proteins; Growth Hormone; Growth Substances; Humans; Inhibins; Phosphorylation; Pituitary Gland; Pituitary Neoplasms; Promoter Regions, Genetic; Protein Binding; Transcription Factor Pit-1; Transcription Factors; Tumor Cells, Cultured	1995
A rat pituitary tumor cell line (GH3) expresses type I and type II receptors and other cell surface binding protein(s) for transforming growth factor-beta. The Journal of biological chemistry, 1995, Jan-13, Volume: 270, Issue:2 Topics: Activins; Animals; Base Sequence; Cells, Cultured; DNA Primers; Inhibins; Membrane Proteins; Molecular Sequence Data; Pituitary Neoplasms; Polymerase Chain Reaction; Protein Binding; Rats; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Tumor Cells, Cultured	1995
Expression of activin/inhibin subunit messenger ribonucleic acids by gonadotroph adenomas. The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:5 Topics: Activins; Adenoma; Adult; Aged; Base Sequence; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Inhibins; Male; Middle Aged; Molecular Sequence Data; Pituitary Neoplasms; Polymerase Chain Reaction; RNA, Messenger	1994
Effects of recombinant human activin A on growth hormone secretion by human somatotrophinomas in vitro. The Journal of endocrinology, 1993, Volume: 137, Issue:2 Topics: Activins; Aged; Bromocriptine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Growth Substances; Humans; Inhibins; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Recombinant Proteins; Stimulation, Chemical; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured	1993
Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:2 Topics: Activin Receptors; Activins; Adenoma; Adolescent; Adult; Alternative Splicing; Amino Acid Sequence; Base Sequence; Gene Expression; Humans; Inhibins; Middle Aged; Molecular Sequence Data; Pituitary Neoplasms; Polymerase Chain Reaction; Receptors, Growth Factor; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transforming Growth Factor beta	1996
Expression and localization of inhibin/activin and activin receptors in GH3 cells, a rat pituitary adenocarcinoma cell line. Journal of endocrinological investigation, 1996, Volume: 19, Issue:1 Topics: Activin Receptors; Activins; Adenocarcinoma; Animals; Base Sequence; DNA, Complementary; Electrophoresis, Agar Gel; Immunohistochemistry; In Situ Hybridization; Inhibins; Molecular Sequence Data; Pituitary Neoplasms; Polymerase Chain Reaction; Rats; Receptors, Growth Factor; Tumor Cells, Cultured	1996
Demonstration of activin in normal pituitary and in various human pituitary adenomas by immunohistochemistry. Endocrine journal, 1996, Volume: 43, Issue:4 Topics: Activins; Adenoma; Cushing Syndrome; Human Growth Hormone; Humans; Immunohistochemistry; Inhibins; Peptides; Pituitary Gland; Pituitary Neoplasms; Prolactinoma	1996
Expression of Pit-1 mRNA and activin/inhibin subunits in clinically nonfunctioning pituitary adenomas. In situ hybridization and immunohistochemical analysis. Hormone research, 1998, Volume: 50, Issue:1 Topics: Activins; Adenoma; Adult; Aged; DNA-Binding Proteins; Female; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Gene Expression; Humans; Immunohistochemistry; In Situ Hybridization; Inhibins; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; RNA, Messenger; Transcription Factor Pit-1; Transcription Factors	1998
Activin effects on neoplastic proliferation of human pituitary tumors. The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:3 Topics: Activin Receptors; Activins; Adenoma; Adult; Aged; Aged, 80 and over; Blotting, Western; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Female; Growth Substances; Humans; Inhibins; Male; Middle Aged; Pituitary Neoplasms; Receptors, Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Thymidine; Tumor Cells, Cultured	2000
A human pituitary tumor-derived folliculostellate cell line. The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:3 Topics: Activin Receptors; Activins; Adenoma; Aged; Blotting, Western; Cell Transformation, Neoplastic; Chromosomes; Enzyme-Linked Immunosorbent Assay; Follistatin; Glycoproteins; Growth Substances; Humans; Immunohistochemistry; Inhibins; Luciferases; Male; Microscopy, Electron; Mutation; Pituitary Neoplasms; Receptors, Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2000
Effect of activin on production and secretion of prolactin and growth hormone in cultured rat GH3 cells. European journal of endocrinology, 2000, Volume: 142, Issue:5 Topics: Activins; Animals; Blotting, Northern; Gene Expression; Growth Hormone; Inhibins; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Rats; RNA, Messenger; Time Factors; Tumor Cells, Cultured	2000
Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling. Molecular endocrinology (Baltimore, Md.), 2000, Volume: 14, Issue:12 Topics: Activin Receptors, Type I; Activin Receptors, Type II; Activins; Adenoma; Animals; Bacterial Proteins; Cell Division; Cell Line; COS Cells; Genes, jun; Genes, Reporter; Humans; Inhibins; K562 Cells; Macromolecular Substances; Phosphorylation; Pituitary Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-jun; Receptors, Growth Factor; Recombinant Fusion Proteins; RNA, Messenger; Sequence Deletion; Signal Transduction; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured	2000
In vitro secretion of FSH by cultured clinically nonfunctioning and gonadotroph pituitary adenomas is directly correlated with locally produced levels of activin A. Clinical endocrinology, 2001, Volume: 54, Issue:4 Topics: Activins; Adenoma; Adult; Aged; Analysis of Variance; Culture Media; Female; Follicle Stimulating Hormone; Follistatin; Humans; Inhibin-beta Subunits; Inhibins; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	2001
Localization of inhibin/activin subunits in normal pituitary and in pituitary adenomas. Pituitary, 2000, Volume: 3, Issue:3 Topics: Activins; Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Immunohistochemistry; Inhibins; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Protein Isoforms; Tissue Distribution	2000
Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology, 2002, Volume: 143, Issue:5 Topics: Activin Receptors; Activins; Amino Acid Sequence; Animals; Binding, Competitive; Cell Line; COS Cells; Follistatin; Follistatin-Related Proteins; Glycoproteins; Heparin; Humans; Ligands; Luciferases; Male; Mice; Molecular Sequence Data; Pituitary Gland; Pituitary Neoplasms; Protein Binding; Proteoglycans; Rats; Rats, Sprague-Dawley; Recombinant Proteins	2002
Effects of activin A and somatostatin on intact FSH secretion and intracellular Ca2+ concentration in human FSH-secreting pituitary adenoma cells. Biochemical and biophysical research communications, 1992, Feb-14, Volume: 182, Issue:3 Topics: Activins; Adenoma; Calcium; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Humans; In Vitro Techniques; Inhibins; Kinetics; Nitrendipine; Pituitary Neoplasms; Somatostatin; Tumor Cells, Cultured	1992
The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas. The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:6 Topics: Activins; Adenoma; Adult; Aged; Animals; Female; Follicle Stimulating Hormone; Glycoproteins; Homeostasis; Hormones; Humans; Inhibins; Middle Aged; Pituitary Neoplasms; Rats; Rats, Inbred Strains; Recombinant Proteins; RNA, Messenger; Tumor Cells, Cultured	1991
Inhibition of growth hormone secretion by activin A in human growth hormone-secreting tumour cells. Acta endocrinologica, 1991, Volume: 124, Issue:6 Topics: Activins; Adult; Calcimycin; Calcium; Cytoplasm; Dose-Response Relationship, Drug; Female; Growth Hormone; Humans; Inhibins; Male; Middle Aged; Pituitary Neoplasms; Tetradecanoylphorbol Acetate; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured	1991
Transforming growth factor-alpha and -beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation. Endocrinology, 1991, Volume: 128, Issue:4 Topics: Activins; Animals; Cell Adhesion; Cell Count; Cell Division; DNA; Inhibins; Interphase; Mitosis; Phorbol 12,13-Dibutyrate; Pituitary Neoplasms; Prolactin; Protein Kinase C; Rats; Recombinant Proteins; S Phase; Tetradecanoylphorbol Acetate; Transforming Growth Factor alpha; Transforming Growth Factor beta; Tumor Cells, Cultured	1991
A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin. The Journal of biological chemistry, 1988, Nov-25, Volume: 263, Issue:33 Topics: Activin Receptors; Activins; Animals; Binding, Competitive; Cell Line; Cell Membrane; Inhibins; Kinetics; Oligopeptides; Peptides; Pituitary Neoplasms; Receptors, Cell Surface; Receptors, Peptide; Receptors, Transforming Growth Factor beta; Transforming Growth Factors	1988